• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma


10.4000 USD 0.00000.00%

As of 20:10:00 ET on 09/10/2014.

Snapshot for BTG PLC (BTGGF)

Open: 10.4000 Day's Range: 10.4000 - 10.4000 Volume: 1,650
Previous Close: 10.4000 52wk Range: 5.7800 - 11.3300 1-Yr Rtn: -

Stock Chart for BTGGF

No chart data available.
  • BTGGF:US 10.4000
  • 1D
  • 1M
  • 1Y
Interactive BTGGF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BTGGF

Current P/E Ratio (ttm) -
Estimated P/E(03/2015) 40.5863
Relative P/E vs. SPX -
Earnings Per Share (GBP) (ttm) -
Est. EPS (GBP) (03/2015) 0.1580
Est. PEG Ratio -
Market Cap (M USD) 3,771.44
Shares Outstanding (M) 362.64
30 Day Average Volume 432
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/12/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BTGGF

  • Revenue
  • Net Income (M/GBP)
  • Profit Margin (%)

Company Profile & Key Executives for BTGGF

BTG plc licenses, develops and commercializes pharmaceuticals and has a pipeline of development programs targeting neurological and other disorders, including varicose veins. The Company also has a substantial and growing revenue stream of milestone payments and royalties from out-licensed products.

Louise MakinCEO/Executive DirectorRolf SoderstromCFO/Executive Director
Peter StratfordCTO:Interventional MedicineGuenter R JanhoferChief Medical Officer/Head:Dev
More Company Profile & Key Executives for BTGGF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil